ArticleBMC ophthalmology2017

Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland.

Oliver Reich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.